Anti-interleukin-2 receptor monoclonal antibody 33B3-1
Alternative Names: 33B3.1; Anti-CD25 monoclonal antibody 33B3.1; Interleukin-2 receptor monoclonal antibody 33B3.1Latest Information Update: 04 Apr 2022
Price :
$50 *
At a glance
- Originator Immunotech
- Developer Immunotech; Nonindustrial source; sanofi pasteur
- Class Monoclonal antibodies
- Mechanism of Action Interleukin 2 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Transplant rejection
Most Recent Events
- 05 Jul 1999 No-Development-Reported for Transplant rejection in France (IV-infusion)
- 18 Mar 1996 New profile
- 18 Mar 1996 Phase-II clinical trials for Transplant rejection in France (IV-infusion)